TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

7.60$ +1.1% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 173 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
175 157 203 176 149 138 131 132 130 136 246 207 175 155 180 186 204 215 235 192 438 466 441 456 429 414 413 384 335 314 257 292 238 226 200 185 234 227 186 173
110 91 138 111 84 74 65 68 68 75 179 139 107 87 103 105 125 114 136 93 308 332 290 289 251 213 206 171 126 112 60 100 50 46 23 13 134 133 95 79
95 76 114 97 65 60 52 43 46 53 158 122 93 62 92 79 114 100 119 74 257 292 248 228 208 179 165 143 106 76 53 94 45 40 18 9.5 3.5 3.0 35 19
95 76 124 97 70 60 52 43 46 53 158 122 93 62 92 79 114 100 119 74 262 307 263 238 218 193 189 158 106 76 53 94 45 40 18 9.5 3.5 3.0 35 19
10 11 6.8 3.9 2.2 1.1 1.1 11 6.1 0.9 0.8 2.2 2.3 16 2.6 17 1.4 1.2 2.2 1.4 22 1.5 1.3 19 8.8 2.7 1.4 1.3 1.0 26 0.5 0.7 0.2 0.4 0.4 0.7 6.3 1.8 54 15
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 7.4 6.9 7.7 8.2 11 11 14 18 20 22 29 22 14 11 8.7 16 0.0 0.0 – – – – – – – – –
24 26 25 26 26 26 27 27 26 25 26 26 33 26 28 29 27 60 27 61 50 91 76 127 139 133 140 174 – – – – – – – – – – – –
23 22 23 23 23 23 23 23 23 23 23 23 23 23 23 24 25 25 24 25 25 25 25 24 24 25 26 25 25 25 25 25 25 24 24 24 24 24 24 24
17 16 16 16 15 32 14 13 13 12 12 11 11 11 10 12 11 11 10.0 9.6 9.0 8.5 7.8 7.7 6.9 6.2 5.7 5.0 4.5 4.4 4.2 4.1 4.0 3.4 3.3 3.2 3.1 3.0 3.0 2.9
196 196 194 194 201 214 244 245 262 311 365 368 380 387 383 412 411 426 433 448 402 418 414 443 441 468 466 460 451 462 447 513 510 533 523 522 515 505 414 379
35 41 36 33 54 56 30 51 58 68 106 122 133 122 127 142 147 130 138 169 150 157 163 160 173 189 191 204 198 256 256 271 271 221 208 235 287 323 249 232
0.1 0.1 0.1 0.1 20 21 0.1 0.1 0.1 0.1 15 15 15 2.0 2.2 3.2 3.0 2.8 3.5 3.1 2.9 3.4 17 16 15 2.5 12 12 13 146 161 25 183 9.8 5.2 14 12 155 141 31
3.3 5.4 4.8 4.6 6.7 8.1 5.4 10 11 14 13 19 16 14 15 21 21 17 19 19 25 30 35 41 40 41 47 52 41 61 51 51 46 61 64 74 85 83 71 59
126 131 134 139 123 142 13 13 13 13 5.9 – – 13 13 19 19 19 19 19 13 13 – – – 13 13 13 13 13 – – – 30 33 23 24 – – –
-21 -39 8.9 -17 -52 -76 -113 -113 -130 -172 -116 -157 -200 -225 -196 -219 -198 -204 -190 -247 42 34 16 3.4 -20 -61 -59 -93 -129 -160 -201 -241 -292 -326 -342 -355 -274 -271 -221 -199
-879 -905 -924 -955 -991 -1,026 -1,072 -1,096 -1,130 -1,177 -1,159 -1,209 -1,255 -1,285 -1,330 -1,377 -1,428 -1,466 -1,520 -1,603 -1,424 -1,490 -1,538 -1,585 -1,639 -1,710 -1,778 -1,847 -1,909 -1,956 -2,018 -2,071 -2,137 -2,183 -2,208 -2,236 -2,172 -2,183 -2,144 -2,144
4.4 4.4 4.7 5.0 5.0 5.0 5.1 5.3 5.7 7.4 7.4 6.7 6.9 7.3 7.3 8.5 9.1 10 10 11 12 12 13 14 14 15 16 18 19 20 20 21 22 23 24 28 33 35 38 41

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?